• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Better Therapeutics Appoints Major General Elder Granger, M.D., U.S. Army (retired) to its Board of Directors

    11/11/21 8:00:00 AM ET
    $BTTX
    $CERN
    $CI
    $DLHC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Managed Health Care
    Health Care
    Get the next $BTTX alert in real time by email

    Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors.

    "Dr. Granger's track record of leadership in navigating complex policy, regulatory and competitive environments will be welcome additions to the Better Therapeutics board," said David Perry, co-founder and chairman of Better Therapeutics. "His extensive board experience coupled with an unwavering commitment to improving the delivery of healthcare will be invaluable as we work to establish our prescription digital therapeutics as the new standard of care for people with cardiometabolic diseases."

    Dr. Granger joins Better Therapeutics' board with decades of experience in acquisition, operation and integration of managed care programs within the Military Health System. He is currently the president and CEO of The 5Ps, a healthcare, education and leadership consulting organization. Prior to retiring from the U.S. Army in 2009, he served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, DC, where he was the principal advisor to the Assistant Secretary of Defense (Health Affairs) on Department of Defense health plan policy and performance.

    "Improving healthcare systems has been a major passion of mine throughout my career, and Better Therapeutics is on the forefront of developing innovative solutions that could truly change the future of healthcare," said Dr. Granger. "I'm eager to offer my expertise in the healthcare space and help the team move its prescription digital therapeutics towards commercialization to reach more of the millions of people in the U.S. living with cardiometabolic diseases."

    "Dr. Granger is a national treasure," said Kevin Appelbaum, co-founder and chief executive officer. "I'm honored by his decision to serve on our board and, as a fellow veteran, look forward to working closely with him to make our solutions accessible to the more than 10 million veterans, active duty service members and their families, who suffer a disproportionate burden of cardiometabolic disease."

    Dr. Granger currently serves as an independent director and Nominating & Governance Committee member for Cerner (NASDAQ:CERN), an independent director and Chair of the Compliance Committee for Cigna (NYSE:CI), and as an independent director of DLH (NASDAQ:DLHC).

    Boardspan Inc. served as an advisor to Better Therapeutics in this appointment.

    About Better Therapeutics

    Better Therapeutics is a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The cognitive behavioral therapy delivered by Better Therapeutics' PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines. For more information visit: bettertx.com

    BTTX-PR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211111005472/en/

    Get the next $BTTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BTTX
    $CERN
    $CI
    $DLHC

    CompanyDatePrice TargetRatingAnalyst
    The Cigna Group
    $CI
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    The Cigna Group
    $CI
    6/26/2024$400.00Overweight
    Piper Sandler
    The Cigna Group
    $CI
    5/30/2024$388.00Outperform
    Robert W. Baird
    The Cigna Group
    $CI
    3/6/2024$393.00Overweight
    Barclays
    The Cigna Group
    $CI
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    The Cigna Group
    $CI
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    The Cigna Group
    $CI
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    The Cigna Group
    $CI
    1/4/2024$330.00 → $372.00Mkt Perform → Outperform
    Bernstein
    More analyst ratings

    $BTTX
    $CERN
    $CI
    $DLHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Mink Brook Asset Management Llc bought $43,484 worth of shares (10,905 units at $3.99) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      5/8/25 7:37:09 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • Large owner Mink Brook Asset Management Llc bought $102,741 worth of shares (26,133 units at $3.93) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      5/5/25 6:14:36 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • Large owner Mink Brook Asset Management Llc bought $105,675 worth of shares (29,119 units at $3.63) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      4/30/25 4:57:22 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary

    $BTTX
    $CERN
    $CI
    $DLHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Mink Brook Asset Management Llc bought $43,484 worth of shares (10,905 units at $3.99) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      5/8/25 7:37:09 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • Large owner Mink Brook Asset Management Llc bought $102,741 worth of shares (26,133 units at $3.93) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      5/5/25 6:14:36 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • Large owner Mink Brook Asset Management Llc bought $105,675 worth of shares (29,119 units at $3.63) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      4/30/25 4:57:22 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary

    $BTTX
    $CERN
    $CI
    $DLHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Cigna Group downgraded by Bernstein with a new price target

      Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

      2/6/25 7:05:01 AM ET
      $CI
      Medical Specialities
      Health Care
    • Piper Sandler initiated coverage on The Cigna Group with a new price target

      Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

      6/26/24 7:28:18 AM ET
      $CI
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on The Cigna Group with a new price target

      Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00

      5/30/24 7:35:19 AM ET
      $CI
      Medical Specialities
      Health Care

    $BTTX
    $CERN
    $CI
    $DLHC
    SEC Filings

    See more
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/8/25 4:11:59 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/7/25 5:13:55 PM ET
      $CI
      Medical Specialities
      Health Care
    • DLH Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - DLH Holdings Corp. (0000785557) (Filer)

      5/7/25 4:37:41 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary

    $BTTX
    $CERN
    $CI
    $DLHC
    Leadership Updates

    Live Leadership Updates

    See more

    $BTTX
    $CERN
    $CI
    $DLHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement

      As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to

      9/9/24 7:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • MultiPlan Announces CFO Transition

      MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

      8/1/24 6:00:00 AM ET
      $DOOR
      $MPLN
      $ORCL
      $CERN
      Forest Products
      Basic Materials
      Business Services
      Consumer Discretionary
    • Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

      One million prescriptions for AspyreRx will be offered to patients in underserved communities disproportionately affected by type 2 diabetes Better Therapeutics, Inc. (NASDAQ:BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced a major partnership with the American College of Lifestyle Medicine's (ACLM) National Training Initiative (NTI), aimed at improving diabetes outcomes in underserved communities across the United States. Through this partnership, Better Therapeutics is committed to making one million prescriptions of its U.S. Food and Drug Administration (FDA)-authorized product, AspyreRx, available to support

      3/5/24 9:25:00 AM ET
      $BTTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • DLH to Continue Providing R&D and Advanced Technology Services to the Telemedicine and Advanced Technology Research Center

      ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security, today announced that it has been awarded a five year task order valued at up to $37.7 million to continue delivering scientific research and development (R&D), modeling & simulation, artificial intelligence, machine learning, robotic process automation, biomedical engineering, and cloud-enabled big data analytic solutions for the Telemedicine and Advanced Technology Research Center ("TATRC"), a direct reporting unit of the US Army Medical Research & Dev

      5/8/25 4:00:00 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • DLH Reports Fiscal 2025 Second Quarter Results

      ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2025. Second Quarter Highlights Second quarter revenue was $89.2 million in fiscal 2025 versus $101.0 million in fiscal 2024, reflecting small business conversions partially offset by contributions from contract awards.Earnings were $0.9 million, or $0.06 per diluted share, for the second quarter of fiscal 2025 versus $1.8 million, or $0.12 pe

      5/7/25 4:30:00 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • The Cigna Group Reports Strong First Quarter 2025 Results, Raises 2025 Outlook

      Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin

      5/2/25 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care

    $BTTX
    $CERN
    $CI
    $DLHC
    Financials

    Live finance-specific insights

    See more
    • DLH Reports Fiscal 2025 Second Quarter Results

      ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2025. Second Quarter Highlights Second quarter revenue was $89.2 million in fiscal 2025 versus $101.0 million in fiscal 2024, reflecting small business conversions partially offset by contributions from contract awards.Earnings were $0.9 million, or $0.06 per diluted share, for the second quarter of fiscal 2025 versus $1.8 million, or $0.12 pe

      5/7/25 4:30:00 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • The Cigna Group Reports Strong First Quarter 2025 Results, Raises 2025 Outlook

      Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin

      5/2/25 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • DLH to Announce Fiscal 2025 Second Quarter Financial Results

      ATLANTA, April 28, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ:DLHC) ("DLH" or the "Company"), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release financial results for the fiscal second quarter ended March 31, 2025 on May 7, 2025 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time the following day, May 8, 2025, during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow.   Inte

      4/28/25 8:00:00 AM ET
      $DLHC
      Professional Services
      Consumer Discretionary

    $BTTX
    $CERN
    $CI
    $DLHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by The Cigna Group

      SC 13G - Cigna Group (0001739940) (Subject)

      11/12/24 9:55:14 AM ET
      $CI
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DLH Holdings Corp.

      SC 13G/A - DLH Holdings Corp. (0000785557) (Subject)

      11/5/24 4:02:13 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G filed by DLH Holdings Corp.

      SC 13G - DLH Holdings Corp. (0000785557) (Subject)

      10/17/24 1:19:53 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary